NCT03179046 Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus Status COMPLETED Phase N/A
NCT03165682 Fatigue, Depression, and Cortical Excitability in Systemic Lupus Status UNKNOWN Phase N/A
NCT03159936 Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Status TERMINATED Phase EARLY_PHASE1
NCT03142711 Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus Status COMPLETED Phase N/A
NCT03142412 Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization Status UNKNOWN Phase N/A
NCT03138941 Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region Status RECRUITING Phase N/A
NCT03107442 Exercise and Arterial Stiffness in Systemic Lupus Erythematosus Status COMPLETED Phase NA
NCT02962960 A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations Status COMPLETED Phase PHASE2
NCT02955615 ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE2
NCT02925351 Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases Status COMPLETED Phase EARLY_PHASE1
NCT02917265 Transcutaneous Vagus Nerve Stimulation for the Treatment of Lupus Status TERMINATED Phase PHASE2
NCT02908100 A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus Status COMPLETED Phase PHASE2